Vascular imaging market will near $6 billion by 2022

By Romily Broad
New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95bill...

New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95 billion by 2022.

The research from MarketsAndMarkets identifies the primary drivers as improving technlogies, aging populations, and the increasing prevelance of cardiovascular diseases (CVDs). It says North America will represent the largest market share geographically, featuring as it does both an aging population susceptible to high rates of CVD and the greatest dispursment of investment in new technlogies.

Of the technologies driving most growth, magnetic resonance imaging will dominate the market in 2017, continuing to be the preferred choice due to its non-invasiveness and high efficacy. 

Coronary angiography will dominate the cardiovascular procedure segment of the market, primarily driven by the ever increasing geriatric population of the world.

The projection sees a overall value uplift of over 25% on a market worth $4.35 billion today.

Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma